MCAM and autoimmune disease: Thus, increased CD146 overexpression has been reported in inflammatory lesions compared to the normal status as inflammatory bowel disease [26], spondylarthritis synovium [27], asthma [28], atherosclerotic plaque formation and progression [29], other autoimmune disorders [30,31,32,33,34], or systemic sclerosis [30,32].